Combination Therapy of RMC-4630 and LY3214996 in Metastatic KRAS Mutant Cancers

Clinical trial NCT04916236 · TERMINATED

Trial details

NCT number: NCT04916236
Sponsor: The Netherlands Cancer Institute
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Cancer Colorectal Cancer Non-small Cell Lung Cancer KRAS Mutation-Related Tumors

Start date: 2022-03-31
Primary completion: 2024-07-30
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.